AU Patent

AU2014216373B2 — Pharmaceutical compositions for the treatment of Helicobacter pylori

Assigned to RED HILL BIOPHARMA Ltd · Expires 2017-12-21 · 8y expired

What this patent protects

Single oral solid dosage form comprising an immediate release first dosage composition having at least two antibiotic agents and a delayed release second dosage composition having a proton pump inhibitor are provided herein. The single oral solid dosage form according to some asp…

USPTO Abstract

Single oral solid dosage form comprising an immediate release first dosage composition having at least two antibiotic agents and a delayed release second dosage composition having a proton pump inhibitor are provided herein. The single oral solid dosage form according to some aspects of the invention can be used for the treatment of disorders associated with infection by

Drugs covered by this patent

Patent Metadata

Patent number
AU2014216373B2
Jurisdiction
AU
Classification
—
Expires
2017-12-21
Drug substance claim
No
Drug product claim
No
Assignee
RED HILL BIOPHARMA Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.